User name

Don't have a user name yet?
Register here.


Swiss Firm Reveals Itself as Lek's Potential Bidder (brief)

Ljubljana, 26 August - Switzerland's Novartis is behind the potential takeover bid of Slovenian pharmaceutical Lek, revealed on Monday Lek chairman of the board Metod Dragonja. "Lek has a great interest in establishing a strategic partnership with long-term orientation, which would affirm Lek's market position on its traditional markets and especially facilitate the penetration to the Western European markets and the United States," stressed Dragonja.

© STA, 2002